<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-07-15" modified="2018-01-31" version="178">
<accession>Q15910</accession>
<accession>B2RAQ1</accession>
<accession>B3KS30</accession>
<accession>B7Z1D6</accession>
<accession>B7Z7L6</accession>
<accession>Q15755</accession>
<accession>Q75MG3</accession>
<accession>Q92857</accession>
<accession>Q96FI6</accession>
<name>EZH2_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="59">Histone-lysine N-methyltransferase EZH2</fullName>
<ecNumber evidence="48">2.1.1.43</ecNumber>
</recommendedName>
<alternativeName>
<fullName>ENX-1</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="58">Enhancer of zeste homolog 2</fullName>
</alternativeName>
<alternativeName>
<fullName>Lysine N-methyltransferase 6</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="61">EZH2</name>
<name type="synonym">KMT6</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Genomics" volume="38" first="30" last="37">
<title>Cloning of a human homolog of the Drosophila enhancer of zeste gene (EZH2) that maps to chromosome 21q22.2.</title>
<authorList>
<person name="Chen H."/>
<person name="Rossier C."/>
<person name="Antonarakis S.E."/>
</authorList>
<dbReference type="PubMed" id="8954776"/>
<dbReference type="DOI" id="10.1006/geno.1996.0588"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="EMBO J." volume="16" first="3219" last="3232">
<title>Mammalian homologues of the Polycomb-group gene Enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S. cerevisiae telomeres.</title>
<authorList>
<person name="Laible G."/>
<person name="Wolf A."/>
<person name="Dorn R."/>
<person name="Reuter G."/>
<person name="Nislow C."/>
<person name="Lebersorger A."/>
<person name="Popkin D."/>
<person name="Pillus L."/>
<person name="Jenuwein T."/>
</authorList>
<dbReference type="PubMed" id="9214638"/>
<dbReference type="DOI" id="10.1093/emboj/16.11.3219"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3; 4 AND 5)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Nature" volume="424" first="157" last="164">
<title>The DNA sequence of human chromosome 7.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Graves T.A."/>
<person name="Pepin K.H."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Maas J."/>
<person name="Jaeger S."/>
<person name="Walker R."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="O'Laughlin M.D."/>
<person name="Schaller M.E."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Cordes M."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Edwards J."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Andrews S."/>
<person name="Isak A."/>
<person name="Vanbrunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Lamar B."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Bielicki L."/>
<person name="Scott K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Harris A."/>
<person name="Strong C.M."/>
<person name="Hou S."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Leonard S."/>
<person name="Rohlfing T."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Abbott A."/>
<person name="Minx P."/>
<person name="Maupin R."/>
<person name="Strowmatt C."/>
<person name="Latreille P."/>
<person name="Miller N."/>
<person name="Johnson D."/>
<person name="Murray J."/>
<person name="Woessner J.P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Schultz B.R."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Nelson J.O."/>
<person name="Berkowicz N."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Bedell J.A."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Chissoe S.L."/>
<person name="Marra M.A."/>
<person name="Raymond C."/>
<person name="Haugen E."/>
<person name="Gillett W."/>
<person name="Zhou Y."/>
<person name="James R."/>
<person name="Phelps K."/>
<person name="Iadanoto S."/>
<person name="Bubb K."/>
<person name="Simms E."/>
<person name="Levy R."/>
<person name="Clendenning J."/>
<person name="Kaul R."/>
<person name="Kent W.J."/>
<person name="Furey T.S."/>
<person name="Baertsch R.A."/>
<person name="Brent M.R."/>
<person name="Keibler E."/>
<person name="Flicek P."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Bailey J.A."/>
<person name="Portnoy M.E."/>
<person name="Torrents D."/>
<person name="Chinwalla A.T."/>
<person name="Gish W.R."/>
<person name="Eddy S.R."/>
<person name="McPherson J.D."/>
<person name="Olson M.V."/>
<person name="Eichler E.E."/>
<person name="Green E.D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="12853948"/>
<dbReference type="DOI" id="10.1038/nature01782"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="3066" last="3073">
<title>Interaction of Vav with ENX-1, a putative transcriptional regulator of homeobox gene expression.</title>
<authorList>
<person name="Hobert O."/>
<person name="Jallal B."/>
<person name="Ullrich A."/>
</authorList>
<dbReference type="PubMed" id="8649418"/>
<dbReference type="DOI" id="10.1128/MCB.16.6.3066"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 134-746</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1998" name="Hum. Mol. Genet." volume="7" first="679" last="684">
<title>Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein.</title>
<authorList>
<person name="Cardoso C."/>
<person name="Timsit S."/>
<person name="Villard L."/>
<person name="Khrestchatisky M."/>
<person name="Fontes M."/>
<person name="Colleaux L."/>
</authorList>
<dbReference type="PubMed" id="9499421"/>
<dbReference type="DOI" id="10.1093/hmg/7.4.679"/>
</citation>
<scope>INTERACTION WITH ATRX</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="3586" last="3595">
<title>Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes.</title>
<authorList>
<person name="Sewalt R.G.A.B."/>
<person name="van der Vlag J."/>
<person name="Gunster M.J."/>
<person name="Hamer K.M."/>
<person name="den Blaauwen J.L."/>
<person name="Satijn D.P.E."/>
<person name="Hendrix T."/>
<person name="van Driel R."/>
<person name="Otte A.P."/>
</authorList>
<dbReference type="PubMed" id="9584199"/>
<dbReference type="DOI" id="10.1128/MCB.18.6.3586"/>
</citation>
<scope>INTERACTION WITH EED</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="Nat. Genet." volume="23" first="474" last="478">
<title>Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation.</title>
<authorList>
<person name="van der Vlag J."/>
<person name="Otte A.P."/>
</authorList>
<dbReference type="PubMed" id="10581039"/>
<dbReference type="DOI" id="10.1038/70602"/>
</citation>
<scope>INTERACTION WITH EED; HDAC1 AND HDAC2</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="1360" last="1369">
<title>The polycomb group protein EED interacts with YY1, and both proteins induce neural tissue in Xenopus embryos.</title>
<authorList>
<person name="Satijn D.P.E."/>
<person name="Hamer K.M."/>
<person name="den Blaauwen J."/>
<person name="Otte A.P."/>
</authorList>
<dbReference type="PubMed" id="11158321"/>
<dbReference type="DOI" id="10.1128/MCB.21.4.1360-1369.2001"/>
</citation>
<scope>INTERACTION WITH EED</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="Genes Dev." volume="16" first="2893" last="2905">
<title>Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein.</title>
<authorList>
<person name="Kuzmichev A."/>
<person name="Nishioka K."/>
<person name="Erdjument-Bromage H."/>
<person name="Tempst P."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="12435631"/>
<dbReference type="DOI" id="10.1101/gad.1035902"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN THE PRC2 COMPLEX WITH EED; RBBP4; RBBP7 AND SUZ12</scope>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX</scope>
<scope>MUTAGENESIS OF CYS-588 AND HIS-689</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="5539" last="5553">
<title>Selective interactions between vertebrate polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of Polycomb group proteins.</title>
<authorList>
<person name="Sewalt R.G.A.B."/>
<person name="Lachner M."/>
<person name="Vargas M."/>
<person name="Hamer K.M."/>
<person name="den Blaauwen J.L."/>
<person name="Hendrix T."/>
<person name="Melcher M."/>
<person name="Schweizer D."/>
<person name="Jenuwein T."/>
<person name="Otte A.P."/>
</authorList>
<dbReference type="PubMed" id="12101246"/>
<dbReference type="DOI" id="10.1128/MCB.22.15.5539-5553.2002"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="Science" volume="298" first="1039" last="1043">
<title>Role of histone H3 lysine 27 methylation in Polycomb-group silencing.</title>
<authorList>
<person name="Cao R."/>
<person name="Wang L."/>
<person name="Wang H."/>
<person name="Xia L."/>
<person name="Erdjument-Bromage H."/>
<person name="Tempst P."/>
<person name="Jones R.S."/>
<person name="Zhang Y."/>
</authorList>
<dbReference type="PubMed" id="12351676"/>
<dbReference type="DOI" id="10.1126/science.1076997"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN THE PRC2 COMPLEX WITH EED; RBBP4; RBBP7 AND SUZ12</scope>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="EMBO J." volume="22" first="5323" last="5335">
<title>EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.</title>
<authorList>
<person name="Bracken A.P."/>
<person name="Pasini D."/>
<person name="Capra M."/>
<person name="Prosperini E."/>
<person name="Colli E."/>
<person name="Helin K."/>
</authorList>
<dbReference type="PubMed" id="14532106"/>
<dbReference type="DOI" id="10.1093/emboj/cdg542"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DEVELOPMENTAL STAGE</scope>
<scope>INDUCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="4061" last="4071">
<title>Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity.</title>
<authorList>
<person name="Pasini D."/>
<person name="Bracken A.P."/>
<person name="Jensen M.R."/>
<person name="Lazzerini Denchi E."/>
<person name="Helin K."/>
</authorList>
<dbReference type="PubMed" id="15385962"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600402"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EED AND SUZ12</scope>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="Genes Dev." volume="18" first="1592" last="1605">
<title>Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.</title>
<authorList>
<person name="Kirmizis A."/>
<person name="Bartley S.M."/>
<person name="Kuzmichev A."/>
<person name="Margueron R."/>
<person name="Reinberg D."/>
<person name="Green R."/>
<person name="Farnham P.J."/>
</authorList>
<dbReference type="PubMed" id="15231737"/>
<dbReference type="DOI" id="10.1101/gad.1200204"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="Mol. Cell" volume="14" first="183" last="193">
<title>Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3.</title>
<authorList>
<person name="Kuzmichev A."/>
<person name="Jenuwein T."/>
<person name="Tempst P."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="15099518"/>
<dbReference type="DOI" id="10.1016/S1097-2765(04)00185-6"/>
</citation>
<scope>CHARACTERIZATION OF THE PRC2 AND PRC3 COMPLEXES INCLUDING EED; EZH2; RBBP4; RBBP7 AND SUZ12</scope>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC2 AND PRC3 COMPLEXES</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2004" name="Mol. Cell" volume="15" first="57" last="67">
<title>SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex.</title>
<authorList>
<person name="Cao R."/>
<person name="Zhang Y."/>
</authorList>
<dbReference type="PubMed" id="15225548"/>
<dbReference type="DOI" id="10.1016/j.molcel.2004.06.020"/>
</citation>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF THE PRC2 COMPLEX INCLUDING AEBP2; EED; EZH2; RBBP4 AND SUZ12</scope>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="5759" last="5769">
<title>Activated p53 suppresses the histone methyltransferase EZH2 gene.</title>
<authorList>
<person name="Tang X."/>
<person name="Milyavsky M."/>
<person name="Shats I."/>
<person name="Erez N."/>
<person name="Goldfinger N."/>
<person name="Rotter V."/>
</authorList>
<dbReference type="PubMed" id="15208672"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207706"/>
</citation>
<scope>DEVELOPMENTAL STAGE</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2005" name="Cell" volume="122" first="835" last="847">
<title>The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling.</title>
<authorList>
<person name="Epping M.T."/>
<person name="Wang L."/>
<person name="Edel M.J."/>
<person name="Carlee L."/>
<person name="Hernandez M."/>
<person name="Bernards R."/>
</authorList>
<dbReference type="PubMed" id="16179254"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.07.003"/>
</citation>
<scope>FUNCTION IN RETINOIC ACID SIGNALING</scope>
<scope>INTERACTION WITH PRAME</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="1859" last="1864">
<title>Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.</title>
<authorList>
<person name="Kuzmichev A."/>
<person name="Margueron R."/>
<person name="Vaquero A."/>
<person name="Preissner T.S."/>
<person name="Scher M."/>
<person name="Kirmizis A."/>
<person name="Ouyang X."/>
<person name="Brockdorff N."/>
<person name="Abate-Shen C."/>
<person name="Farnham P.J."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="15684044"/>
<dbReference type="DOI" id="10.1073/pnas.0409875102"/>
</citation>
<scope>CHARACTERIZATION OF THE PRC4 COMPLEX INCLUDING EED; EZH2; RBBP4; RBBP7; SUZ12 AND SIRT1</scope>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC4 COMPLEX</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="Science" volume="310" first="306" last="310">
<title>Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3.</title>
<authorList>
<person name="Cha T.-L."/>
<person name="Zhou B.P."/>
<person name="Xia W."/>
<person name="Wu Y."/>
<person name="Yang C.-C."/>
<person name="Chen C.-T."/>
<person name="Ping B."/>
<person name="Otte A.P."/>
<person name="Hung M.-C."/>
</authorList>
<dbReference type="PubMed" id="16224021"/>
<dbReference type="DOI" id="10.1126/science.1118947"/>
</citation>
<scope>INTERACTION WITH EED AND SUZ12</scope>
<scope>PHOSPHORYLATION AT SER-21 BY AKT1</scope>
<scope>MUTAGENESIS OF SER-21</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-487</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="Genes Dev." volume="20" first="1123" last="1136">
<title>Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.</title>
<authorList>
<person name="Bracken A.P."/>
<person name="Dietrich N."/>
<person name="Pasini D."/>
<person name="Hansen K.H."/>
<person name="Helin K."/>
</authorList>
<dbReference type="PubMed" id="16618801"/>
<dbReference type="DOI" id="10.1101/gad.381706"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="8365" last="8370">
<title>Substrate preferences of the EZH2 histone methyltransferase complex.</title>
<authorList>
<person name="Martin C."/>
<person name="Cao R."/>
<person name="Zhang Y."/>
</authorList>
<dbReference type="PubMed" id="16431907"/>
<dbReference type="DOI" id="10.1074/jbc.M513425200"/>
</citation>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="21209" last="21215">
<title>The polycomb group protein EZH2 is required for mammalian circadian clock function.</title>
<authorList>
<person name="Etchegaray J.P."/>
<person name="Yang X."/>
<person name="DeBruyne J.P."/>
<person name="Peters A.H."/>
<person name="Weaver D.R."/>
<person name="Jenuwein T."/>
<person name="Reppert S.M."/>
</authorList>
<dbReference type="PubMed" id="16717091"/>
<dbReference type="DOI" id="10.1074/jbc.M603722200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-487</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2006" name="Nature" volume="439" first="871" last="874">
<title>The Polycomb group protein EZH2 directly controls DNA methylation.</title>
<authorList>
<person name="Vire E."/>
<person name="Brenner C."/>
<person name="Deplus R."/>
<person name="Blanchon L."/>
<person name="Fraga M."/>
<person name="Didelot C."/>
<person name="Morey L."/>
<person name="Van Eynde A."/>
<person name="Bernard D."/>
<person name="Vanderwinden J.-M."/>
<person name="Bollen M."/>
<person name="Esteller M."/>
<person name="Di Croce L."/>
<person name="de Launoit Y."/>
<person name="Fuks F."/>
</authorList>
<dbReference type="PubMed" id="16357870"/>
<dbReference type="DOI" id="10.1038/nature04431"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION OF THE PRC2 COMPLEX WITH DNMT1; DNMT3A AND DNMT3B</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="Nature" volume="446" first="824" last="824">
<authorList>
<person name="Vire E."/>
<person name="Brenner C."/>
<person name="Deplus R."/>
<person name="Blanchon L."/>
<person name="Fraga M."/>
<person name="Didelot C."/>
<person name="Morey L."/>
<person name="Van Eynde A."/>
<person name="Bernard D."/>
<person name="Vanderwinden J.-M."/>
<person name="Bollen M."/>
<person name="Esteller M."/>
<person name="Di Croce L."/>
<person name="de Launoit Y."/>
<person name="Fuks F."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Nat. Struct. Mol. Biol." volume="13" first="793" last="797">
<title>Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells.</title>
<authorList>
<person name="Kim D.H."/>
<person name="Villeneuve L.M."/>
<person name="Morris K.V."/>
<person name="Rossi J.J."/>
</authorList>
<dbReference type="PubMed" id="16936726"/>
<dbReference type="DOI" id="10.1038/nsmb1142"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2007" name="Genes Dev." volume="21" first="49" last="54">
<title>pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene.</title>
<authorList>
<person name="Kotake Y."/>
<person name="Cao R."/>
<person name="Viatour P."/>
<person name="Sage J."/>
<person name="Zhang Y."/>
<person name="Xiong Y."/>
</authorList>
<dbReference type="PubMed" id="17210787"/>
<dbReference type="DOI" id="10.1101/gad.1499407"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2007" name="Genes Dev." volume="21" first="525" last="530">
<title>The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells.</title>
<authorList>
<person name="Bracken A.P."/>
<person name="Kleine-Kohlbrecher D."/>
<person name="Dietrich N."/>
<person name="Pasini D."/>
<person name="Gargiulo G."/>
<person name="Beekman C."/>
<person name="Theilgaard-Moench K."/>
<person name="Minucci S."/>
<person name="Porse B.T."/>
<person name="Marine J.-C."/>
<person name="Hansen K.H."/>
<person name="Helin K."/>
</authorList>
<dbReference type="PubMed" id="17344414"/>
<dbReference type="DOI" id="10.1101/gad.415507"/>
</citation>
<scope>FUNCTION</scope>
<scope>DEVELOPMENTAL STAGE</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2007" name="Nat. Genet." volume="39" first="232" last="236">
<title>Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer.</title>
<authorList>
<person name="Schlesinger Y."/>
<person name="Straussman R."/>
<person name="Keshet I."/>
<person name="Farkash S."/>
<person name="Hecht M."/>
<person name="Zimmerman J."/>
<person name="Eden E."/>
<person name="Yakhini Z."/>
<person name="Ben-Shushan E."/>
<person name="Reubinoff B.E."/>
<person name="Bergman Y."/>
<person name="Simon I."/>
<person name="Cedar H."/>
</authorList>
<dbReference type="PubMed" id="17200670"/>
<dbReference type="DOI" id="10.1038/ng1950"/>
</citation>
<scope>DE NOVO DNA METHYLATION OF PRC2 TARGET GENES</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-487</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-487</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2008" name="Mol. Cell" volume="32" first="503" last="518">
<title>Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms.</title>
<authorList>
<person name="Margueron R."/>
<person name="Li G."/>
<person name="Sarma K."/>
<person name="Blais A."/>
<person name="Zavadil J."/>
<person name="Woodcock C.L."/>
<person name="Dynlacht B.D."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="19026781"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.11.004"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE PRC2/EED-EZH1 COMPLEX</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="1862" last="1872">
<title>Role of hPHF1 in H3K27 methylation and Hox gene silencing.</title>
<authorList>
<person name="Cao R."/>
<person name="Wang H."/>
<person name="He J."/>
<person name="Erdjument-Bromage H."/>
<person name="Tempst P."/>
<person name="Zhang Y."/>
</authorList>
<dbReference type="PubMed" id="18086877"/>
<dbReference type="DOI" id="10.1128/MCB.01589-07"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN THE PRC2 COMPLEX</scope>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="2718" last="2731">
<title>Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo.</title>
<authorList>
<person name="Sarma K."/>
<person name="Margueron R."/>
<person name="Ivanov A."/>
<person name="Pirrotta V."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="18285464"/>
<dbReference type="DOI" id="10.1128/MCB.02017-07"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EED; SUZ12 AND PHF1</scope>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX</scope>
<scope>MUTAGENESIS OF HIS-689</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2008" name="PLoS ONE" volume="3" first="E2704" last="E2704">
<title>The polycomb repressive complex 2 is a potential target of SUMO modifications.</title>
<authorList>
<person name="Riising E.M."/>
<person name="Boggio R."/>
<person name="Chiocca S."/>
<person name="Helin K."/>
<person name="Pasini D."/>
</authorList>
<dbReference type="PubMed" id="18628979"/>
<dbReference type="DOI" id="10.1371/journal.pone.0002704"/>
</citation>
<scope>SUMOYLATION</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-366; THR-367 AND THR-487</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-487</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="44">
<citation type="journal article" date="2010" name="Nat. Cell Biol." volume="12" first="1108" last="1114">
<title>Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2.</title>
<authorList>
<person name="Chen S."/>
<person name="Bohrer L.R."/>
<person name="Rai A.N."/>
<person name="Pan Y."/>
<person name="Gan L."/>
<person name="Zhou X."/>
<person name="Bagchi A."/>
<person name="Simon J.A."/>
<person name="Huang H."/>
</authorList>
<dbReference type="PubMed" id="20935635"/>
<dbReference type="DOI" id="10.1038/ncb2116"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT THR-345 BY CDK1 AND CDK2</scope>
<scope>MUTAGENESIS OF THR-345</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-487</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="46">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="42414" last="42425">
<title>Corepressor protein CDYL functions as a molecular bridge between polycomb repressor complex 2 and repressive chromatin mark trimethylated histone lysine 27.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Yang X."/>
<person name="Gui B."/>
<person name="Xie G."/>
<person name="Zhang D."/>
<person name="Shang Y."/>
<person name="Liang J."/>
</authorList>
<dbReference type="PubMed" id="22009739"/>
<dbReference type="DOI" id="10.1074/jbc.M111.271064"/>
</citation>
<scope>INTERACTION WITH CDYL</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-487</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2012" name="Mol. Cell" volume="48" first="572" last="586">
<title>EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex.</title>
<authorList>
<person name="Lee J.M."/>
<person name="Lee J.S."/>
<person name="Kim H."/>
<person name="Kim K."/>
<person name="Park H."/>
<person name="Kim J.Y."/>
<person name="Lee S.H."/>
<person name="Kim I.S."/>
<person name="Kim J."/>
<person name="Lee M."/>
<person name="Chung C.H."/>
<person name="Seo S.B."/>
<person name="Yoon J.B."/>
<person name="Ko E."/>
<person name="Noh D.Y."/>
<person name="Kim K.I."/>
<person name="Kim K.K."/>
<person name="Baek S.H."/>
</authorList>
<dbReference type="PubMed" id="23063525"/>
<dbReference type="DOI" id="10.1016/j.molcel.2012.09.004"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76; THR-339; SER-363; THR-367 AND THR-487</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="50">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="1355" last="1360">
<title>O-GlcNAcylation regulates EZH2 protein stability and function.</title>
<authorList>
<person name="Chu C.S."/>
<person name="Lo P.W."/>
<person name="Yeh Y.H."/>
<person name="Hsu P.H."/>
<person name="Peng S.H."/>
<person name="Teng Y.C."/>
<person name="Kang M.L."/>
<person name="Wong C.H."/>
<person name="Juan L.J."/>
</authorList>
<dbReference type="PubMed" id="24474760"/>
<dbReference type="DOI" id="10.1073/pnas.1323226111"/>
</citation>
<scope>GLYCOSYLATION AT SER-75</scope>
<scope>MUTAGENESIS OF SER-75</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-634</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2010" name="Nat. Genet." volume="42" first="181" last="185">
<title>Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.</title>
<authorList>
<person name="Morin R.D."/>
<person name="Johnson N.A."/>
<person name="Severson T.M."/>
<person name="Mungall A.J."/>
<person name="An J."/>
<person name="Goya R."/>
<person name="Paul J.E."/>
<person name="Boyle M."/>
<person name="Woolcock B.W."/>
<person name="Kuchenbauer F."/>
<person name="Yap D."/>
<person name="Humphries R.K."/>
<person name="Griffith O.L."/>
<person name="Shah S."/>
<person name="Zhu H."/>
<person name="Kimbara M."/>
<person name="Shashkin P."/>
<person name="Charlot J.F."/>
<person name="Tcherpakov M."/>
<person name="Corbett R."/>
<person name="Tam A."/>
<person name="Varhol R."/>
<person name="Smailus D."/>
<person name="Moksa M."/>
<person name="Zhao Y."/>
<person name="Delaney A."/>
<person name="Qian H."/>
<person name="Birol I."/>
<person name="Schein J."/>
<person name="Moore R."/>
<person name="Holt R."/>
<person name="Horsman D.E."/>
<person name="Connors J.M."/>
<person name="Jones S."/>
<person name="Aparicio S."/>
<person name="Hirst M."/>
<person name="Gascoyne R.D."/>
<person name="Marra M.A."/>
</authorList>
<dbReference type="PubMed" id="20081860"/>
<dbReference type="DOI" id="10.1038/ng.518"/>
</citation>
<scope>VARIANTS PHE-641; SER-641; ASN-641; HIS-641 AND CYS-641</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2010" name="Nat. Genet." volume="42" first="722" last="726">
<title>Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.</title>
<authorList>
<person name="Ernst T."/>
<person name="Chase A.J."/>
<person name="Score J."/>
<person name="Hidalgo-Curtis C.E."/>
<person name="Bryant C."/>
<person name="Jones A.V."/>
<person name="Waghorn K."/>
<person name="Zoi K."/>
<person name="Ross F.M."/>
<person name="Reiter A."/>
<person name="Hochhaus A."/>
<person name="Drexler H.G."/>
<person name="Duncombe A."/>
<person name="Cervantes F."/>
<person name="Oscier D."/>
<person name="Boultwood J."/>
<person name="Grand F.H."/>
<person name="Cross N.C."/>
</authorList>
<dbReference type="PubMed" id="20601953"/>
<dbReference type="DOI" id="10.1038/ng.621"/>
</citation>
<scope>VARIANTS TRP-571; CYS-641; CYS-685 AND ASP-726</scope>
<scope>CHARACTERIZATION OF VARIANTS TRP-571; CYS-641; CYS-685 AND ASP-726</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2011" name="Blood" volume="117" first="2451" last="2459">
<title>Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation.</title>
<authorList>
<person name="Yap D.B."/>
<person name="Chu J."/>
<person name="Berg T."/>
<person name="Schapira M."/>
<person name="Cheng S.W."/>
<person name="Moradian A."/>
<person name="Morin R.D."/>
<person name="Mungall A.J."/>
<person name="Meissner B."/>
<person name="Boyle M."/>
<person name="Marquez V.E."/>
<person name="Marra M.A."/>
<person name="Gascoyne R.D."/>
<person name="Humphries R.K."/>
<person name="Arrowsmith C.H."/>
<person name="Morin G.B."/>
<person name="Aparicio S.A."/>
</authorList>
<dbReference type="PubMed" id="21190999"/>
<dbReference type="DOI" id="10.1182/blood-2010-11-321208"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS PHE-641 AND ASN-641</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2011" name="Blood" volume="118" first="3932" last="3941">
<title>Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.</title>
<authorList>
<person name="Jankowska A.M."/>
<person name="Makishima H."/>
<person name="Tiu R.V."/>
<person name="Szpurka H."/>
<person name="Huang Y."/>
<person name="Traina F."/>
<person name="Visconte V."/>
<person name="Sugimoto Y."/>
<person name="Prince C."/>
<person name="O'Keefe C."/>
<person name="Hsi E.D."/>
<person name="List A."/>
<person name="Sekeres M.A."/>
<person name="Rao A."/>
<person name="McDevitt M.A."/>
<person name="Maciejewski J.P."/>
</authorList>
<dbReference type="PubMed" id="21828135"/>
<dbReference type="DOI" id="10.1182/blood-2010-10-311019"/>
</citation>
<scope>VARIANT HIS-685</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2011" name="Oncotarget" volume="2" first="1127" last="1133">
<title>Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height.</title>
<authorList>
<consortium name="Childhood Overgrowth Collaboration"/>
<person name="Tatton-Brown K."/>
<person name="Hanks S."/>
<person name="Ruark E."/>
<person name="Zachariou A."/>
<person name="Duarte S.V."/>
<person name="Ramsay E."/>
<person name="Snape K."/>
<person name="Murray A."/>
<person name="Perdeaux E.R."/>
<person name="Seal S."/>
<person name="Loveday C."/>
<person name="Banka S."/>
<person name="Clericuzio C."/>
<person name="Flinter F."/>
<person name="Magee A."/>
<person name="McConnell V."/>
<person name="Patton M."/>
<person name="Raith W."/>
<person name="Rankin J."/>
<person name="Splitt M."/>
<person name="Strenger V."/>
<person name="Taylor C."/>
<person name="Wheeler P."/>
<person name="Temple K.I."/>
<person name="Cole T."/>
<person name="Douglas J."/>
<person name="Rahman N."/>
</authorList>
<dbReference type="PubMed" id="22190405"/>
<dbReference type="DOI" id="10.18632/oncotarget.385"/>
</citation>
<scope>VARIANTS WVS THR-134; GLU-156; ARG-279; MET-621; ASN-658; THR-677; CYS-679; LEU-690; 728-TYR--PRO-746 DEL AND CYS-736</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2012" name="Am. J. Hum. Genet." volume="90" first="110" last="118">
<title>Mutations in EZH2 cause Weaver syndrome.</title>
<authorList>
<person name="Gibson W.T."/>
<person name="Hood R.L."/>
<person name="Zhan S.H."/>
<person name="Bulman D.E."/>
<person name="Fejes A.P."/>
<person name="Moore R."/>
<person name="Mungall A.J."/>
<person name="Eydoux P."/>
<person name="Babul-Hirji R."/>
<person name="An J."/>
<person name="Marra M.A."/>
<person name="Chitayat D."/>
<person name="Boycott K.M."/>
<person name="Weaver D.D."/>
<person name="Jones S.J."/>
</authorList>
<dbReference type="PubMed" id="22177091"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2011.11.018"/>
</citation>
<scope>VARIANTS WVS SER-132; TYR-153 DEL AND TYR-689</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="2989" last="2994">
<title>Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27).</title>
<authorList>
<person name="McCabe M.T."/>
<person name="Graves A.P."/>
<person name="Ganji G."/>
<person name="Diaz E."/>
<person name="Halsey W.S."/>
<person name="Jiang Y."/>
<person name="Smitheman K.N."/>
<person name="Ott H.M."/>
<person name="Pappalardi M.B."/>
<person name="Allen K.E."/>
<person name="Chen S.B."/>
<person name="Della Pietra A. III"/>
<person name="Dul E."/>
<person name="Hughes A.M."/>
<person name="Gilbert S.A."/>
<person name="Thrall S.H."/>
<person name="Tummino P.J."/>
<person name="Kruger R.G."/>
<person name="Brandt M."/>
<person name="Schwartz B."/>
<person name="Creasy C.L."/>
</authorList>
<dbReference type="PubMed" id="22323599"/>
<dbReference type="DOI" id="10.1073/pnas.1116418109"/>
</citation>
<scope>VARIANT GLY-677</scope>
<scope>CHARACTERIZATION OF VARIANTS ASN-641; CYS-641; HIS-641; PHE-641 AND GLY-677</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2013" name="Am. J. Med. Genet. A" volume="161A" first="225" last="227">
<title>Weaver syndrome and defective cortical development: a rare association.</title>
<authorList>
<person name="Al-Salem A."/>
<person name="Alshammari M.J."/>
<person name="Hassan H."/>
<person name="Alazami A.M."/>
<person name="Alkuraya F.S."/>
</authorList>
<dbReference type="PubMed" id="23239504"/>
<dbReference type="DOI" id="10.1002/ajmg.a.35660"/>
</citation>
<scope>VARIANT WVS LYS-740</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2016" name="Hum. Mutat." volume="37" first="301" last="307">
<title>Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro.</title>
<authorList>
<person name="Cohen A.S."/>
<person name="Yap D.B."/>
<person name="Lewis M.E."/>
<person name="Chijiwa C."/>
<person name="Ramos-Arroyo M.A."/>
<person name="Tkachenko N."/>
<person name="Milano V."/>
<person name="Fradin M."/>
<person name="McKinnon M.L."/>
<person name="Townsend K.N."/>
<person name="Xu J."/>
<person name="Van Allen M.I."/>
<person name="Ross C.J."/>
<person name="Dobyns W.B."/>
<person name="Weaver D.D."/>
<person name="Gibson W.T."/>
</authorList>
<dbReference type="PubMed" id="26694085"/>
<dbReference type="DOI" id="10.1002/humu.22946"/>
</citation>
<scope>VARIANTS WVS CYS-133 AND CYS-679</scope>
<scope>CHARACTERIZATION OF VARIANTS WVS SER-132; CYS-133; TYR-153 DEL; CYS-679 AND TYR-689</scope>
<scope>VARIANT HIS-185</scope>
<scope>CHARACTERIZATION OF VARIANT HIS-185</scope>
<scope>MUTAGENESIS OF PHE-667</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="637" last="648">
<title>Mutations in genes encoding polycomb repressive complex 2 subunits cause Weaver syndrome.</title>
<authorList>
<person name="Imagawa E."/>
<person name="Higashimoto K."/>
<person name="Sakai Y."/>
<person name="Numakura C."/>
<person name="Okamoto N."/>
<person name="Matsunaga S."/>
<person name="Ryo A."/>
<person name="Sato Y."/>
<person name="Sanefuji M."/>
<person name="Ihara K."/>
<person name="Takada Y."/>
<person name="Nishimura G."/>
<person name="Saitsu H."/>
<person name="Mizuguchi T."/>
<person name="Miyatake S."/>
<person name="Nakashima M."/>
<person name="Miyake N."/>
<person name="Soejima H."/>
<person name="Matsumoto N."/>
</authorList>
<dbReference type="PubMed" id="28229514"/>
<dbReference type="DOI" id="10.1002/humu.23200"/>
</citation>
<scope>INVOLVEMENT IN WVS</scope>
</reference>
<comment type="function">
<text evidence="24 26 27 28 29 31 32 33 34 35 36 38 40 43 48 49 51">Polycomb group (PcG) protein. Catalytic subunit of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene. Able to mono-, di- and trimethylate 'Lys-27' of histone H3 to form H3K27me1, H3K27me2 and H3K27me3, respectively. Displays a preference for substrates with less methylation, loses activity when progressively more methyl groups are incorporated into H3K27, H3K27me0 > H3K27me1 > H3K27me2 (PubMed:22323599). Compared to EZH1-containing complexes, it is more abundant in embryonic stem cells and plays a major role in forming H3K27me3, which is required for embryonic stem cell identity and proper differentiation. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems. Genes repressed by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1, CDKN2A and retinoic acid target genes. EZH2 can also methylate non-histone proteins such as the transcription factor GATA4 and the nuclear receptor RORA. Regulates the circadian clock via histone methylation at the promoter of the circadian genes. Essential for the CRY1/2-mediated repression of the transcriptional activation of PER1/2 by the CLOCK-ARNTL/BMAL1 heterodimer; involved in the di and trimethylation of 'Lys-27' of histone H3 on PER1/2 promoters which is necessary for the CRY1/2 proteins to inhibit transcription.</text>
</comment>
<comment type="catalytic activity">
<text evidence="48">S-adenosyl-L-methionine + L-lysine-[histone] = S-adenosyl-L-homocysteine + N(6)-methyl-L-lysine-[histone].</text>
</comment>
<comment type="subunit">
<text evidence="16 19 20 22 23 28 29 30 31 37 38 40 45 54 55 59">Binds ATRX via the SET domain (Probable). Component of the PRC2/EED-EZH2 complex, which includes EED, EZH2, SUZ12, RBBP4 and RBBP7 and possibly AEBP2. The minimum components required for methyltransferase activity of the PRC2/EED-EZH2 complex are EED, EZH2 and SUZ12. The PRC2 complex may also interact with DNMT1, DNMT3A, DNMT3B and PHF1 via the EZH2 subunit and with SIRT1 via the SUZ12 subunit. Interacts with HDAC1 and HDAC2. Interacts with PRAME. Interacts with CDYL. Interacts with CLOCK, ARNTL/BMAL1 and CRY1 (By similarity). Interacts with DNMT3L; the interaction is direct (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-530054"/>
<interactant intactId="EBI-1646500">
<id>Q8IXJ9</id>
<label>ASXL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-530054"/>
<interactant intactId="EBI-396461">
<id>P46100</id>
<label>ATRX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-530054"/>
<interactant intactId="EBI-741977">
<id>Q96MT8</id>
<label>CEP63</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-530054"/>
<interactant intactId="EBI-719459">
<id>P26358</id>
<label>DNMT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-530054"/>
<interactant intactId="EBI-923653">
<id>Q9Y6K1</id>
<label>DNMT3A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-530054"/>
<interactant intactId="EBI-80125">
<id>Q9UBC3</id>
<label>DNMT3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-530054"/>
<interactant intactId="EBI-3043871">
<id>Q9CWR8</id>
<label>Dnmt3l</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-530054"/>
<interactant intactId="EBI-923794">
<id>O75530</id>
<label>EED</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-530054"/>
<interactant intactId="EBI-15825247">
<id>Q92833-1</id>
<label>JARID2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-10699473"/>
<interactant intactId="EBI-10172052">
<id>P60411</id>
<label>KRTAP10-9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-530054"/>
<interactant intactId="EBI-7172227">
<id>Q9Y4K0</id>
<label>LOXL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-530054"/>
<interactant intactId="EBI-530034">
<id>O43189</id>
<label>PHF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-530054"/>
<interactant intactId="EBI-867256">
<id>Q15156</id>
<label>PML-RAR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-530054"/>
<interactant intactId="EBI-413374">
<id>P10276</id>
<label>RARA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-530054"/>
<interactant intactId="EBI-518675">
<id>P40763</id>
<label>STAT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-530054"/>
<interactant intactId="EBI-349968">
<id>O43463</id>
<label>SUV39H1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-530054"/>
<interactant intactId="EBI-1264675">
<id>Q15022</id>
<label>SUZ12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="21 24 27 55">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q15910-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q15910-2</id>
<name>2</name>
<sequence type="described" ref="VSP_038815"/>
</isoform>
<isoform>
<id>Q15910-3</id>
<name>3</name>
<sequence type="described" ref="VSP_038814"/>
</isoform>
<isoform>
<id>Q15910-4</id>
<name>4</name>
<sequence type="described" ref="VSP_038813"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>Q15910-5</id>
<name>5</name>
<sequence type="described" ref="VSP_038813 VSP_038816"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="24">Expressed in many tissues. Overexpressed in numerous tumor types including carcinomas of the breast, colon, larynx, lymphoma and testis.</text>
</comment>
<comment type="developmental stage">
<text evidence="24 25 36">Expression decreases during senescence of embryonic fibroblasts (HEFs). Expression peaks at the G1/S phase boundary.</text>
</comment>
<comment type="induction">
<text evidence="24 25 36">Expression is induced by E2F1, E2F2 and E2F3. Expression is reduced in cells subject to numerous types of stress including UV-, IR- and bleomycin-induced DNA damage and by activation of p53/TP53.</text>
</comment>
<comment type="PTM">
<text evidence="30 43">Phosphorylated by AKT1. Phosphorylation by AKT1 reduces methyltransferase activity. Phosphorylation at Thr-345 by CDK1 and CDK2 promotes maintenance of H3K27me3 levels at EZH2-target loci, thus leading to epigenetic gene silencing.</text>
</comment>
<comment type="PTM">
<text evidence="39">Sumoylated.</text>
</comment>
<comment type="PTM">
<text evidence="51">Glycosylated: O-GlcNAcylation at Ser-75 by OGT increases stability of EZH2 and facilitates the formation of H3K27me3 by the PRC2/EED-EZH2 complex.</text>
</comment>
<comment type="disease" evidence="46 47 50 52 53">
<disease id="DI-01141">
<name>Weaver syndrome</name>
<acronym>WVS</acronym>
<description>A syndrome of accelerated growth and osseous maturation, unusual craniofacial appearance, hoarse and low-pitched cry, and hypertonia with camptodactyly. Distinguishing features of Weaver syndrome include broad forehead and face, ocular hypertelorism, prominent wide philtrum, micrognathia, deep horizontal chin groove, and deep-set nails. In addition, carpal bone development is advanced over the rest of the hand.</description>
<dbReference type="MIM" id="277590"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="17">Belongs to the class V-like SAM-binding methyltransferase superfamily. Histone-lysine methyltransferase family. EZ subfamily.</text>
</comment>
<comment type="caution">
<text evidence="60">Two variants of the PRC2 complex have been described, termed PRC3 and PRC4. Each of the three complexes may include a different complement of EED isoforms, although the precise sequences of the isoforms in each complex have not been determined. The PRC2 and PRC4 complexes may also methylate 'Lys-26' of histone H1 in addition to 'Lys-27' of histone H3 (PubMed:15099518 and PubMed:15684044), although other studies have demonstrated no methylation of 'Lys-26' of histone H1 by PRC2 (PubMed:16431907).</text>
</comment>
<comment type="sequence caution" evidence="59">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="AAS07448" version="1"/>
</conflict>
</comment>
<dbReference type="EC" id="2.1.1.43" evidence="48"/>
<dbReference type="EMBL" id="X95653">
<property type="protein sequence ID" value="CAA64955.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U61145">
<property type="protein sequence ID" value="AAC51520.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK302216">
<property type="protein sequence ID" value="BAH13652.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK092676">
<property type="protein sequence ID" value="BAG52592.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK293239">
<property type="protein sequence ID" value="BAH11472.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314291">
<property type="protein sequence ID" value="BAG36948.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC006323">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC073140">
<property type="protein sequence ID" value="AAS07448.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471146">
<property type="protein sequence ID" value="EAW80067.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471146">
<property type="protein sequence ID" value="EAW80070.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC010858">
<property type="protein sequence ID" value="AAH10858.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U52965">
<property type="protein sequence ID" value="AAC50591.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS56516.1">
<molecule id="Q15910-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS56517.1">
<molecule id="Q15910-5"/>
</dbReference>
<dbReference type="CCDS" id="CCDS56518.1">
<molecule id="Q15910-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5891.1">
<molecule id="Q15910-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5892.1">
<molecule id="Q15910-3"/>
</dbReference>
<dbReference type="PIR" id="G02838">
<property type="entry name" value="G02838"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001190176.1">
<molecule id="Q15910-1"/>
<property type="nucleotide sequence ID" value="NM_001203247.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001190177.1">
<molecule id="Q15910-4"/>
<property type="nucleotide sequence ID" value="NM_001203248.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001190178.1">
<molecule id="Q15910-5"/>
<property type="nucleotide sequence ID" value="NM_001203249.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004447.2">
<molecule id="Q15910-2"/>
<property type="nucleotide sequence ID" value="NM_004456.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_694543.1">
<molecule id="Q15910-3"/>
<property type="nucleotide sequence ID" value="NM_152998.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011514186.1">
<molecule id="Q15910-2"/>
<property type="nucleotide sequence ID" value="XM_011515884.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.444082"/>
<dbReference type="UniGene" id="Hs.732308"/>
<dbReference type="PDB" id="2C6V">
<property type="method" value="Model"/>
<property type="chains" value="A=508-734"/>
</dbReference>
<dbReference type="PDB" id="4MI0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=520-746"/>
</dbReference>
<dbReference type="PDB" id="4MI5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=521-746"/>
</dbReference>
<dbReference type="PDB" id="5GSA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.49"/>
<property type="chains" value="C/D=40-68"/>
</dbReference>
<dbReference type="PDB" id="5H14">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="C/D=40-68"/>
</dbReference>
<dbReference type="PDB" id="5H15">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.27"/>
<property type="chains" value="C/D=40-68"/>
</dbReference>
<dbReference type="PDB" id="5H17">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="B=40-68"/>
</dbReference>
<dbReference type="PDB" id="5H19">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="B=40-68"/>
</dbReference>
<dbReference type="PDB" id="5H24">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="C/D=40-68"/>
</dbReference>
<dbReference type="PDB" id="5H25">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.88"/>
<property type="chains" value="C/D=40-68"/>
</dbReference>
<dbReference type="PDB" id="5HYN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A/F/K/Q=1-746"/>
</dbReference>
<dbReference type="PDB" id="5IJ7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.62"/>
<property type="chains" value="A/B=429-487, A/B=511-746"/>
</dbReference>
<dbReference type="PDB" id="5IJ8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.99"/>
<property type="chains" value="A/B=429-487, A/B=511-531, A/B=533-746"/>
</dbReference>
<dbReference type="PDB" id="5LS6">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.47"/>
<property type="chains" value="A/D/G/J=1-385, A/D/G/J=421-746"/>
</dbReference>
<dbReference type="PDB" id="5U5T">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="C/D=39-68"/>
</dbReference>
<dbReference type="PDB" id="5U62">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="C/D=39-68"/>
</dbReference>
<dbReference type="PDB" id="5WUK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="B=41-68"/>
</dbReference>
<dbReference type="PDBsum" id="2C6V"/>
<dbReference type="PDBsum" id="4MI0"/>
<dbReference type="PDBsum" id="4MI5"/>
<dbReference type="PDBsum" id="5GSA"/>
<dbReference type="PDBsum" id="5H14"/>
<dbReference type="PDBsum" id="5H15"/>
<dbReference type="PDBsum" id="5H17"/>
<dbReference type="PDBsum" id="5H19"/>
<dbReference type="PDBsum" id="5H24"/>
<dbReference type="PDBsum" id="5H25"/>
<dbReference type="PDBsum" id="5HYN"/>
<dbReference type="PDBsum" id="5IJ7"/>
<dbReference type="PDBsum" id="5IJ8"/>
<dbReference type="PDBsum" id="5LS6"/>
<dbReference type="PDBsum" id="5U5T"/>
<dbReference type="PDBsum" id="5U62"/>
<dbReference type="PDBsum" id="5WUK"/>
<dbReference type="ProteinModelPortal" id="Q15910"/>
<dbReference type="SMR" id="Q15910"/>
<dbReference type="BioGrid" id="108446">
<property type="interactions" value="280"/>
</dbReference>
<dbReference type="CORUM" id="Q15910"/>
<dbReference type="DIP" id="DIP-34002N"/>
<dbReference type="IntAct" id="Q15910">
<property type="interactions" value="114"/>
</dbReference>
<dbReference type="MINT" id="MINT-1371596"/>
<dbReference type="STRING" id="9606.ENSP00000320147"/>
<dbReference type="BindingDB" id="Q15910"/>
<dbReference type="ChEMBL" id="CHEMBL2189110"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2654"/>
<dbReference type="iPTMnet" id="Q15910"/>
<dbReference type="PhosphoSitePlus" id="Q15910"/>
<dbReference type="BioMuta" id="EZH2"/>
<dbReference type="DMDM" id="3334180"/>
<dbReference type="EPD" id="Q15910"/>
<dbReference type="MaxQB" id="Q15910"/>
<dbReference type="PaxDb" id="Q15910"/>
<dbReference type="PeptideAtlas" id="Q15910"/>
<dbReference type="PRIDE" id="Q15910"/>
<dbReference type="DNASU" id="2146"/>
<dbReference type="Ensembl" id="ENST00000320356">
<molecule id="Q15910-2"/>
<property type="protein sequence ID" value="ENSP00000320147"/>
<property type="gene ID" value="ENSG00000106462"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000350995">
<molecule id="Q15910-3"/>
<property type="protein sequence ID" value="ENSP00000223193"/>
<property type="gene ID" value="ENSG00000106462"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000460911">
<molecule id="Q15910-1"/>
<property type="protein sequence ID" value="ENSP00000419711"/>
<property type="gene ID" value="ENSG00000106462"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000476773">
<molecule id="Q15910-5"/>
<property type="protein sequence ID" value="ENSP00000419050"/>
<property type="gene ID" value="ENSG00000106462"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000478654">
<molecule id="Q15910-5"/>
<property type="protein sequence ID" value="ENSP00000417062"/>
<property type="gene ID" value="ENSG00000106462"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000483967">
<molecule id="Q15910-4"/>
<property type="protein sequence ID" value="ENSP00000419856"/>
<property type="gene ID" value="ENSG00000106462"/>
</dbReference>
<dbReference type="GeneID" id="2146"/>
<dbReference type="KEGG" id="hsa:2146"/>
<dbReference type="UCSC" id="uc003wfb.3">
<molecule id="Q15910-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2146"/>
<dbReference type="DisGeNET" id="2146"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000106462.10"/>
<dbReference type="GeneCards" id="EZH2"/>
<dbReference type="GeneReviews" id="EZH2"/>
<dbReference type="HGNC" id="HGNC:3527">
<property type="gene designation" value="EZH2"/>
</dbReference>
<dbReference type="HPA" id="CAB009589"/>
<dbReference type="HPA" id="HPA029131"/>
<dbReference type="MalaCards" id="EZH2"/>
<dbReference type="MIM" id="277590">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601573">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q15910"/>
<dbReference type="OpenTargets" id="ENSG00000106462"/>
<dbReference type="Orphanet" id="3447">
<property type="disease" value="Weaver syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27939"/>
<dbReference type="eggNOG" id="KOG1079">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG2940">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119228"/>
<dbReference type="HOVERGEN" id="HBG002453"/>
<dbReference type="InParanoid" id="Q15910"/>
<dbReference type="KO" id="K11430"/>
<dbReference type="OMA" id="VYNYTPC"/>
<dbReference type="PhylomeDB" id="Q15910"/>
<dbReference type="TreeFam" id="TF314509"/>
<dbReference type="Reactome" id="R-HSA-212300">
<property type="pathway name" value="PRC2 methylates histones and DNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559580">
<property type="pathway name" value="Oxidative Stress Induced Senescence"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3214841">
<property type="pathway name" value="PKMTs methylate histone lysines"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5617472">
<property type="pathway name" value="Activation of anterior HOX genes in hindbrain development during early embryogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8943724">
<property type="pathway name" value="Regulation of PTEN gene transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8953750">
<property type="pathway name" value="Transcriptional Regulation by E2F6"/>
</dbReference>
<dbReference type="SignaLink" id="Q15910"/>
<dbReference type="SIGNOR" id="Q15910"/>
<dbReference type="ChiTaRS" id="EZH2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="EZH2"/>
<dbReference type="GenomeRNAi" id="2146"/>
<dbReference type="PRO" id="PR:Q15910"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 7"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000106462"/>
<dbReference type="CleanEx" id="HS_EZH2"/>
<dbReference type="ExpressionAtlas" id="Q15910">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q15910">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035098">
<property type="term" value="C:ESC/E(Z) complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045120">
<property type="term" value="C:pronucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031490">
<property type="term" value="F:chromatin DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001047">
<property type="term" value="F:core promoter binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042054">
<property type="term" value="F:histone methyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0046976">
<property type="term" value="F:histone methyltransferase activity (H3-K27 specific)"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018024">
<property type="term" value="F:histone-lysine N-methyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070878">
<property type="term" value="F:primary miRNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990841">
<property type="term" value="F:promoter-specific chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016279">
<property type="term" value="F:protein-lysine N-methyltransferase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043021">
<property type="term" value="F:ribonucleoprotein complex binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000979">
<property type="term" value="F:RNA polymerase II core promoter sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014898">
<property type="term" value="P:cardiac muscle hypertrophy in response to stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070301">
<property type="term" value="P:cellular response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035984">
<property type="term" value="P:cellular response to trichostatin A"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0021695">
<property type="term" value="P:cerebellar cortex development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006325">
<property type="term" value="P:chromatin organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006306">
<property type="term" value="P:DNA methylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070314">
<property type="term" value="P:G1 to G0 transition"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0036333">
<property type="term" value="P:hepatocyte homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0021766">
<property type="term" value="P:hippocampus development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070734">
<property type="term" value="P:histone H3-K27 methylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098532">
<property type="term" value="P:histone H3-K27 trimethylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016571">
<property type="term" value="P:histone methylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097421">
<property type="term" value="P:liver regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043433">
<property type="term" value="P:negative regulation of DNA binding transcription factor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045605">
<property type="term" value="P:negative regulation of epidermal cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070317">
<property type="term" value="P:negative regulation of G0 to G1 transition"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:2000134">
<property type="term" value="P:negative regulation of G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045814">
<property type="term" value="P:negative regulation of gene expression, epigenetic"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048387">
<property type="term" value="P:negative regulation of retinoic acid receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051154">
<property type="term" value="P:negative regulation of striated muscle cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034244">
<property type="term" value="P:negative regulation of transcription elongation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900006">
<property type="term" value="P:positive regulation of dendrite development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010718">
<property type="term" value="P:positive regulation of epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043547">
<property type="term" value="P:positive regulation of GTPase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043406">
<property type="term" value="P:positive regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071902">
<property type="term" value="P:positive regulation of protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071168">
<property type="term" value="P:protein localization to chromatin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042752">
<property type="term" value="P:regulation of circadian rhythm"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014013">
<property type="term" value="P:regulation of gliogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0032355">
<property type="term" value="P:response to estradiol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904772">
<property type="term" value="P:response to tetrachloromethane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048511">
<property type="term" value="P:rhythmic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0014834">
<property type="term" value="P:skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd00167">
<property type="entry name" value="SANT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR026489">
<property type="entry name" value="CXC_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR021654">
<property type="entry name" value="EZH1/EZH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR001005">
<property type="entry name" value="SANT/Myb"/>
</dbReference>
<dbReference type="InterPro" id="IPR001214">
<property type="entry name" value="SET_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR033467">
<property type="entry name" value="Tesmin/TSO1-like_CXC"/>
</dbReference>
<dbReference type="Pfam" id="PF11616">
<property type="entry name" value="EZH2_WD-Binding"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00856">
<property type="entry name" value="SET"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01114">
<property type="entry name" value="CXC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00717">
<property type="entry name" value="SANT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00317">
<property type="entry name" value="SET"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51633">
<property type="entry name" value="CXC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50280">
<property type="entry name" value="SET"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0156">Chromatin regulator</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0489">Methyltransferase</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0949">S-adenosyl-L-methionine</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Histone-lysine N-methyltransferase EZH2" id="PRO_0000213992">
<location>
<begin position="1"/>
<end position="746"/>
</location>
</feature>
<feature type="domain" description="CXC" evidence="18">
<location>
<begin position="503"/>
<end position="605"/>
</location>
</feature>
<feature type="domain" description="SET" evidence="17">
<location>
<begin position="612"/>
<end position="727"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DNMT1, DNMT3A and DNMT3B">
<location>
<begin position="1"/>
<end position="340"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with EED" evidence="15">
<location>
<begin position="39"/>
<end position="68"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CDYL" evidence="45">
<location>
<begin position="329"/>
<end position="522"/>
</location>
</feature>
<feature type="compositionally biased region" description="Cys-rich">
<location>
<begin position="523"/>
<end position="605"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKB/AKT1" evidence="30">
<location>
<position position="21"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="76"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="13">
<location>
<position position="339"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK1 and CDK2" evidence="43">
<location>
<position position="345"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="363"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="366"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8 13">
<location>
<position position="367"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5 6 7 8 9 10 11 12 13">
<location>
<position position="487"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) serine" evidence="51">
<location>
<position position="75"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="634"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4 and isoform 5." id="VSP_038813" evidence="56">
<location>
<begin position="74"/>
<end position="82"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_038814" evidence="56">
<location>
<begin position="83"/>
<end position="121"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_038815" evidence="57">
<original>HP</original>
<variation>HRKCNYS</variation>
<location>
<begin position="297"/>
<end position="298"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_038816" evidence="56">
<original>DGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSEC</original>
<variation>G</variation>
<location>
<begin position="511"/>
<end position="553"/>
</location>
</feature>
<feature type="sequence variant" description="In WVS; decreased histone methyltransferase activity; dbSNP:rs193921148." id="VAR_067595" evidence="46 52">
<original>P</original>
<variation>S</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="In WVS; decreased histone methyltransferase activity." id="VAR_078320" evidence="52">
<original>Y</original>
<variation>C</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="sequence variant" description="In WVS." id="VAR_078321" evidence="47">
<original>M</original>
<variation>T</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="sequence variant" description="In WVS; decreased histone methyltransferase activity." id="VAR_067596" evidence="46 52">
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In WVS." id="VAR_078322" evidence="47">
<original>K</original>
<variation>E</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorhism; decreased histone methyltransferase activity; dbSNP:rs2302427." id="VAR_055795" evidence="52">
<original>D</original>
<variation>H</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="sequence variant" description="In WVS." id="VAR_078323" evidence="47">
<original>H</original>
<variation>R</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with myelodysplastic syndrome and myelodysplastic-myeloproliferative neoplasms; somatic mutation; loss of histone methyltransferase activity." id="VAR_078324" evidence="42">
<original>C</original>
<variation>W</variation>
<location>
<position position="571"/>
</location>
</feature>
<feature type="sequence variant" description="In WVS; unknown pathological significance; dbSNP:rs587783625." id="VAR_078325" evidence="47">
<original>V</original>
<variation>M</variation>
<location>
<position position="621"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with diffuse large B-cell lymphoma; somatic mutation; changed substrate preferences; prefers substrates with greater methylation H3K27me0&lt;me1&lt;me2." id="VAR_067228" evidence="41 42 48">
<original>Y</original>
<variation>C</variation>
<location>
<position position="641"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with follicular lymphoma; also in diffuse large B-cell lymphoma; somatic mutation; changed substrate preferences; prefers substrates with greater methylation H3K27me0&lt;me1&lt;me2; dbSNP:rs267601394." id="VAR_067229" evidence="41 48">
<original>Y</original>
<variation>F</variation>
<location>
<position position="641"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with follicular lymphoma; also in diffuse large B-cell lymphoma; somatic mutation; changed substrate preferences; prefers substrates with greater methylation H3K27me0&lt;me1&lt;me2; dbSNP:rs267601395." id="VAR_067230" evidence="41 48">
<original>Y</original>
<variation>H</variation>
<location>
<position position="641"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with follicular lymphoma; also in diffuse large B-cell lymphoma; somatic mutation; changed substrate preferences; prefers substrates with greater methylation H3K27me0&lt;me1&lt;me2." id="VAR_067231" evidence="41 48">
<original>Y</original>
<variation>N</variation>
<location>
<position position="641"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with follicular lymphoma; also in diffuse large B-cell lymphoma; somatic mutation." id="VAR_067232" evidence="41">
<original>Y</original>
<variation>S</variation>
<location>
<position position="641"/>
</location>
</feature>
<feature type="sequence variant" description="In WVS." id="VAR_078326" evidence="47">
<original>Y</original>
<variation>N</variation>
<location>
<position position="658"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with B-cell lymphoma; increased hypertrimethylation of H3K27; changed substrate preferences; confers biochemical activity independent of H3K27 methylation state." id="VAR_078327" evidence="48">
<original>A</original>
<variation>G</variation>
<location>
<position position="677"/>
</location>
</feature>
<feature type="sequence variant" description="In WVS; dbSNP:rs397515547." id="VAR_078328" evidence="47">
<original>A</original>
<variation>T</variation>
<location>
<position position="677"/>
</location>
</feature>
<feature type="sequence variant" description="In WVS; decreased histone methyltransferase activity; dbSNP:rs587783626." id="VAR_078329" evidence="47 52">
<original>R</original>
<variation>C</variation>
<location>
<position position="679"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with myeloid disorders; somatic mutation; loss of histone methyltransferase activity." id="VAR_078330" evidence="42">
<original>R</original>
<variation>C</variation>
<location>
<position position="685"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with chronic myelomonocytic leukemia." id="VAR_067233" evidence="44">
<original>R</original>
<variation>H</variation>
<location>
<position position="685"/>
</location>
</feature>
<feature type="sequence variant" description="In WVS; decreased histone methyltransferase activity; dbSNP:rs193921147." id="VAR_067597" evidence="46 52">
<original>H</original>
<variation>Y</variation>
<location>
<position position="689"/>
</location>
</feature>
<feature type="sequence variant" description="In WVS." id="VAR_078331" evidence="47">
<original>S</original>
<variation>L</variation>
<location>
<position position="690"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with chronic myelomonocytic leukemia; somatic mutation; loss of histone methyltransferase activity." id="VAR_078332" evidence="42">
<original>Y</original>
<variation>D</variation>
<location>
<position position="726"/>
</location>
</feature>
<feature type="sequence variant" description="In WVS." id="VAR_078333" evidence="47">
<location>
<begin position="728"/>
<end position="746"/>
</location>
</feature>
<feature type="sequence variant" description="In WVS." id="VAR_078334" evidence="47">
<original>Y</original>
<variation>C</variation>
<location>
<position position="736"/>
</location>
</feature>
<feature type="sequence variant" description="In WVS; unknown pathological significance; dbSNP:rs397515548." id="VAR_078335" evidence="50">
<original>E</original>
<variation>K</variation>
<location>
<position position="740"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhances methyltransferase activity towards 'Lys-27' of histone H3 and abrogates phosphorylation by PKB/AKT1." evidence="30">
<original>S</original>
<variation>A</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces methyltransferase activity towards 'Lys-27' of histone H3 and abrogates phosphorylation by PKB/AKT1." evidence="30">
<original>S</original>
<variation>D</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced protein stability." evidence="51">
<original>S</original>
<variation>A</variation>
<location>
<position position="75"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired CDK1- and CDK-2 mediated phosphorylation and subsequent gene silencing. Altered EZH2-mediated cell proliferation and migration." evidence="43">
<original>T</original>
<variation>A</variation>
<location>
<position position="345"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly impairs methyltransferase activity towards 'Lys-27' of histone H3." evidence="23">
<original>C</original>
<variation>Y</variation>
<location>
<position position="588"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreases histone methyltransferase activity." evidence="52">
<original>F</original>
<variation>I</variation>
<location>
<position position="667"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates methyltransferase activity." evidence="23 38">
<original>H</original>
<variation>A</variation>
<location>
<position position="689"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG52592." ref="3" evidence="59">
<original>K</original>
<variation>N</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA64955." ref="1" evidence="59">
<original>F</original>
<variation>L</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA64955." ref="1" evidence="59">
<original>F</original>
<variation>V</variation>
<location>
<position position="724"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="44"/>
<end position="62"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="82"/>
<end position="87"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="94"/>
<end position="97"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="99"/>
<end position="101"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="126"/>
<end position="129"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="135"/>
<end position="138"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="139"/>
<end position="143"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="144"/>
<end position="152"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="153"/>
<end position="155"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="161"/>
<end position="163"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="168"/>
<end position="181"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="221"/>
<end position="230"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="232"/>
<end position="234"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="237"/>
<end position="248"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="264"/>
<end position="266"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="274"/>
<end position="284"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="287"/>
<end position="289"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="291"/>
<end position="293"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="304"/>
<end position="306"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="332"/>
<end position="343"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="434"/>
<end position="447"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="451"/>
<end position="458"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="463"/>
<end position="474"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="526"/>
<end position="528"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="535"/>
<end position="538"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="563"/>
<end position="565"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="572"/>
<end position="575"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="582"/>
<end position="584"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="587"/>
<end position="589"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="590"/>
<end position="592"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="594"/>
<end position="596"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="600"/>
<end position="603"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="605"/>
<end position="608"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="614"/>
<end position="618"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="620"/>
<end position="630"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="637"/>
<end position="640"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="643"/>
<end position="647"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="648"/>
<end position="656"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="666"/>
<end position="668"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="670"/>
<end position="676"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="678"/>
<end position="680"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="683"/>
<end position="686"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="687"/>
<end position="689"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="694"/>
<end position="702"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="705"/>
<end position="714"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="721"/>
<end position="723"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4MI0"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5HYN"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5LS6"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5U5T"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250"/>
<evidence key="16" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q61188"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00190"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00970"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10581039"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11158321"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12101246"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12351676"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12435631"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14532106"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15208672"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15225548"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15231737"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15385962"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16179254"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16224021"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16357870"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16618801"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16717091"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16936726"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17210787"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344414"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18086877"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18285464"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18628979"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19026781"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20081860"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20601953"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20935635"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21828135"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22009739"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22177091"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22190405"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22323599"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23063525"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23239504"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24474760"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26694085"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28229514"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9499421"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9584199"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="28229514"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000305"/>
<evidence key="60" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="16431907"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:3527"/>
</source>
</evidence>
<sequence length="746" mass="85363" checksum="1B5029EB9D509BE5" modified="1998-07-15" version="2">
MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEW
KQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNF
MVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQ
YNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEEL
KEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFH
ATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPN
NSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKM
KPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPA
PAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQ
NFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVS
CKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDK
YMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGE
ELFFDYRYSQADALKYVGIEREMEIP
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>